The University of Southampton
University of Southampton Institutional Repository

Anaesthetic-analgesic ear drops to reduce antibiotic consumption in children with acute otitis media: the CEDAR RCT

Anaesthetic-analgesic ear drops to reduce antibiotic consumption in children with acute otitis media: the CEDAR RCT
Anaesthetic-analgesic ear drops to reduce antibiotic consumption in children with acute otitis media: the CEDAR RCT

BACKGROUND: Acute otitis media (AOM) is a common reason for primary care consultations and antibiotic prescribing in children. Options for improved pain control may influence antibiotic prescribing and consumption. 

OBJECTIVE: The Children's Ear Pain Study (CEDAR) investigated whether or not providing anaesthetic-analgesic ear drops reduced antibiotic consumption in children with AOM. Secondary objectives included pain control and cost-effectiveness. 

DESIGN: A multicentre, randomised, parallel-group (two-group initially, then three-group) trial. 

SETTING: Primary care practices in England and Wales. 

PARTICIPANTS: 1- to 10-year-old children presenting within 1 week of suspected AOM onset with ear pain during the preceding 24 hours and not requiring immediate antibiotics. Participating children were logged into the study and allocated using a remote randomisation service. 

INTERVENTIONS: Two-group trial - unblinded comparison of anaesthetic-analgesic ear drops versus usual care. Three-group trial - blinded comparison of anaesthetic-analgesic ear drops versus placebo ear drops and unblinded comparison with usual care. 

MAIN OUTCOME MEASURES: The primary outcome measure was parent-reported antibiotic use by the child over 8 days following enrolment. Secondary measures included ear pain at day 2 and NHS and societal costs over 8 days. 

RESULTS: Owing to a delay in provision of the placebo drops, the recruitment period was shortened and most participants were randomly allocated to the two-group study (n = 74) rather than the three-group study (n = 32). Comparing active drops with usual care in the combined two-group and three-group studies, 1 out of 39 (3%) children allocated to the active drops group and 11 out of 38 (29%) children allocated to the usual-care group consumed antibiotics in the 8 days following enrolment [unadjusted odds ratio 0.09, 95% confidence interval (CI) 0.02 to 0.55; p = 0.009; adjusted for delayed prescribing odds ratio 0.15, 95% CI 0.03 to 0.87; p = 0.035]. A total of 43% (3/7) of patients in the placebo drops group consumed antibiotics by day 8, compared with 0% (0/10) of the three-group study active drops groups (p = 0.051). The economic analysis of NHS costs (£12.66 for active drops and £11.36 for usual care) leads to an estimated cost of £5.19 per antibiotic prescription avoided, but with a high degree of uncertainty. A reduction in ear pain at day 2 in the placebo group (n = 7) compared with the active drops group (n = 10) (adjusted difference in means 0.67, 95% CI -1.44 to 2.79; p = 0.51) is consistent with chance. No adverse events were reported in children receiving active drops. 

LIMITATIONS: Estimated treatment effects are imprecise because the sample size target was not met. It is not clear if delayed prescriptions of an antibiotic were written prior to randomisation. Few children received placebo drops, which hindered the investigation of ear pain. 

CONCLUSIONS: This study suggests that reduced antibiotic use can be achieved in children with AOM by combining a no or delayed antibiotic prescribing strategy with anaesthetic-analgesic ear drops. Whether or not the active drops relieved ear pain was not established. 

FUTURE WORK: The observed reduction in antibiotic consumption following the prescription of ear drops requires replication in a larger study. Future work should establish if the effect of ear drops is due to pain relief.

TRIAL REGISTRATION: Current Controlled Trials ISRCTN09599764. 

FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 34. See the NIHR Journals Library website for further project information. Alastair D Hay was funded by a NIHR Research Professorship (funding identifier NIHR-RP-02-12-012).

ANALGESICS, ANTIBACTERIAL AGENTS, CHILD, EAR ACHE, OTITIS MEDIA
1366-5278
1-48
Hay, Alastair D.
ff494524-3d12-4389-ad51-3fa88c56437b
Downing, Harriet
6f9fc478-f778-4eae-b5ef-f4d3430d59db
Francis, Nick A.
9b610883-605c-4fee-871d-defaa86ccf8e
Young, Grace J.
34e6c6a3-80ca-4a55-b0c8-1b3f51093f21
Clement, Clare
d7ce5b3a-6b2b-478c-a506-982fedeb96d4
Harris, Sue D.
7292c676-5ebb-4307-a180-b817289d5e26
Ahern, Aideen
81a5b766-ec40-45c7-a48c-25d0d4da7ccb
Schofield, Behnaz
0a9a7bef-6f21-4045-b7cc-fc3104d7a843
Thomas, Tammy E.
742fc3b2-61cb-4f87-8466-afa31b3c8d8e
Horwood, Jeremy
17a93c97-cc9f-4914-ab17-9fdb7dc034e4
Blair, Peter S.
3d5e258e-a342-4f3f-98a3-195267ee7456
Hollingworth, William
8a59a64f-787e-4411-8b6c-81139d0b5d15
Wilson, Victoria
3b6ae12b-7629-466a-bbad-599cfb2cc24d
Metcalfe, Chris
516c7009-41ad-4913-b7cd-5f9dffe792b1
Stoddart, Peter
0fb5773c-1b8b-494b-8dba-031f5d8786cb
Nunez, Desmond
e64dd121-f99f-4016-a2d8-ef3ad5b8b2df
Lyttle, Mark D.
8b37d5d4-9dd1-4dfa-b251-7b560f4994c7
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
Moore, Michael V.
1be81dad-7120-45f0-bbed-f3b0cc0cfe99
Hay, Alastair D.
ff494524-3d12-4389-ad51-3fa88c56437b
Downing, Harriet
6f9fc478-f778-4eae-b5ef-f4d3430d59db
Francis, Nick A.
9b610883-605c-4fee-871d-defaa86ccf8e
Young, Grace J.
34e6c6a3-80ca-4a55-b0c8-1b3f51093f21
Clement, Clare
d7ce5b3a-6b2b-478c-a506-982fedeb96d4
Harris, Sue D.
7292c676-5ebb-4307-a180-b817289d5e26
Ahern, Aideen
81a5b766-ec40-45c7-a48c-25d0d4da7ccb
Schofield, Behnaz
0a9a7bef-6f21-4045-b7cc-fc3104d7a843
Thomas, Tammy E.
742fc3b2-61cb-4f87-8466-afa31b3c8d8e
Horwood, Jeremy
17a93c97-cc9f-4914-ab17-9fdb7dc034e4
Blair, Peter S.
3d5e258e-a342-4f3f-98a3-195267ee7456
Hollingworth, William
8a59a64f-787e-4411-8b6c-81139d0b5d15
Wilson, Victoria
3b6ae12b-7629-466a-bbad-599cfb2cc24d
Metcalfe, Chris
516c7009-41ad-4913-b7cd-5f9dffe792b1
Stoddart, Peter
0fb5773c-1b8b-494b-8dba-031f5d8786cb
Nunez, Desmond
e64dd121-f99f-4016-a2d8-ef3ad5b8b2df
Lyttle, Mark D.
8b37d5d4-9dd1-4dfa-b251-7b560f4994c7
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
Moore, Michael V.
1be81dad-7120-45f0-bbed-f3b0cc0cfe99

Hay, Alastair D., Downing, Harriet, Francis, Nick A., Young, Grace J., Clement, Clare, Harris, Sue D., Ahern, Aideen, Schofield, Behnaz, Thomas, Tammy E., Horwood, Jeremy, Blair, Peter S., Hollingworth, William, Wilson, Victoria, Metcalfe, Chris, Stoddart, Peter, Nunez, Desmond, Lyttle, Mark D., Little, Paul and Moore, Michael V. (2019) Anaesthetic-analgesic ear drops to reduce antibiotic consumption in children with acute otitis media: the CEDAR RCT. Health Technology Assessment, 23 (34), 1-48. (doi:10.3310/hta23340).

Record type: Article

Abstract

BACKGROUND: Acute otitis media (AOM) is a common reason for primary care consultations and antibiotic prescribing in children. Options for improved pain control may influence antibiotic prescribing and consumption. 

OBJECTIVE: The Children's Ear Pain Study (CEDAR) investigated whether or not providing anaesthetic-analgesic ear drops reduced antibiotic consumption in children with AOM. Secondary objectives included pain control and cost-effectiveness. 

DESIGN: A multicentre, randomised, parallel-group (two-group initially, then three-group) trial. 

SETTING: Primary care practices in England and Wales. 

PARTICIPANTS: 1- to 10-year-old children presenting within 1 week of suspected AOM onset with ear pain during the preceding 24 hours and not requiring immediate antibiotics. Participating children were logged into the study and allocated using a remote randomisation service. 

INTERVENTIONS: Two-group trial - unblinded comparison of anaesthetic-analgesic ear drops versus usual care. Three-group trial - blinded comparison of anaesthetic-analgesic ear drops versus placebo ear drops and unblinded comparison with usual care. 

MAIN OUTCOME MEASURES: The primary outcome measure was parent-reported antibiotic use by the child over 8 days following enrolment. Secondary measures included ear pain at day 2 and NHS and societal costs over 8 days. 

RESULTS: Owing to a delay in provision of the placebo drops, the recruitment period was shortened and most participants were randomly allocated to the two-group study (n = 74) rather than the three-group study (n = 32). Comparing active drops with usual care in the combined two-group and three-group studies, 1 out of 39 (3%) children allocated to the active drops group and 11 out of 38 (29%) children allocated to the usual-care group consumed antibiotics in the 8 days following enrolment [unadjusted odds ratio 0.09, 95% confidence interval (CI) 0.02 to 0.55; p = 0.009; adjusted for delayed prescribing odds ratio 0.15, 95% CI 0.03 to 0.87; p = 0.035]. A total of 43% (3/7) of patients in the placebo drops group consumed antibiotics by day 8, compared with 0% (0/10) of the three-group study active drops groups (p = 0.051). The economic analysis of NHS costs (£12.66 for active drops and £11.36 for usual care) leads to an estimated cost of £5.19 per antibiotic prescription avoided, but with a high degree of uncertainty. A reduction in ear pain at day 2 in the placebo group (n = 7) compared with the active drops group (n = 10) (adjusted difference in means 0.67, 95% CI -1.44 to 2.79; p = 0.51) is consistent with chance. No adverse events were reported in children receiving active drops. 

LIMITATIONS: Estimated treatment effects are imprecise because the sample size target was not met. It is not clear if delayed prescriptions of an antibiotic were written prior to randomisation. Few children received placebo drops, which hindered the investigation of ear pain. 

CONCLUSIONS: This study suggests that reduced antibiotic use can be achieved in children with AOM by combining a no or delayed antibiotic prescribing strategy with anaesthetic-analgesic ear drops. Whether or not the active drops relieved ear pain was not established. 

FUTURE WORK: The observed reduction in antibiotic consumption following the prescription of ear drops requires replication in a larger study. Future work should establish if the effect of ear drops is due to pain relief.

TRIAL REGISTRATION: Current Controlled Trials ISRCTN09599764. 

FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 34. See the NIHR Journals Library website for further project information. Alastair D Hay was funded by a NIHR Research Professorship (funding identifier NIHR-RP-02-12-012).

Text
CEDAR_HTA_13_88_13_FINAL_REPORT__V2 (adh) - Accepted Manuscript
Download (2MB)
Text
13-88-13-1P - Version of Record
Available under License Creative Commons Attribution.
Download (808kB)

More information

Accepted/In Press date: 31 December 2017
Published date: 1 July 2019
Keywords: ANALGESICS, ANTIBACTERIAL AGENTS, CHILD, EAR ACHE, OTITIS MEDIA

Identifiers

Local EPrints ID: 433279
URI: http://eprints.soton.ac.uk/id/eprint/433279
ISSN: 1366-5278
PURE UUID: b6b03cee-cf70-4680-a11d-a4a4db3c054b
ORCID for Nick A. Francis: ORCID iD orcid.org/0000-0001-8939-7312
ORCID for Michael V. Moore: ORCID iD orcid.org/0000-0002-5127-4509

Catalogue record

Date deposited: 13 Aug 2019 16:30
Last modified: 21 Mar 2020 01:46

Export record

Altmetrics

Contributors

Author: Alastair D. Hay
Author: Harriet Downing
Author: Nick A. Francis ORCID iD
Author: Grace J. Young
Author: Clare Clement
Author: Sue D. Harris
Author: Aideen Ahern
Author: Behnaz Schofield
Author: Tammy E. Thomas
Author: Jeremy Horwood
Author: Peter S. Blair
Author: William Hollingworth
Author: Victoria Wilson
Author: Chris Metcalfe
Author: Peter Stoddart
Author: Desmond Nunez
Author: Mark D. Lyttle
Author: Paul Little

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×